Literature DB >> 21353243

Risk factors for medication-induced diabetes and type 2 diabetes.

Shazhan Amed1, Heather Dean, Elizabeth A C Sellers, Constadina Panagiotopoulos, Baiju R Shah, Gillian L Booth, Tessa A Laubscher, David Dannenbaum, Stasia Hadjiyannakis, Jill K Hamilton.   

Abstract

OBJECTIVE: To compare the prevalence of risk factors in children aged <18 years diagnosed with medication-induced diabetes mellitus versus those diagnosed with type 2 diabetes. STUDY
DESIGN: This retrospective observational study used data from a Canadian prospective surveillance study in which clinical features of new cases of type 2 diabetes (n = 225) and medication-induced diabetes (n = 58) were reported over a 2-year period. The presence of risk factors for type 2 diabetes (eg, obesity, family history of type 2 diabetes, ethnicity, acanthosis nigricans, hypertension, polycystic ovarian syndrome) was compared in the 2 groups using descriptive statistics and logistic regression.
RESULTS: Compared with the children with type 2 diabetes, the children with medication-induced diabetes were more likely to be Caucasian (P < .0001) and less likely to be obese (P < .0001), to have a positive family history of type 2 diabetes (P = .0001), to have acanthosis nigricans (P < .0001) on clinical examination, and to have an obesity-related comorbidity, such as polycystic ovarian syndrome (P = .04), dyslipidemia (P = .02), hypertension (P = .04), or an elevated alanine aminotransferase level (P = .05).
CONCLUSIONS: Evaluating for the typical risk factors for type 2 diabetes is not sufficient to identify all children at risk for developing medication-induced diabetes. Further studies are needed to help inform guidelines on screening for and prevention of medication-induced diabetes in children.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21353243     DOI: 10.1016/j.jpeds.2011.01.017

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

1.  Medication induced diabetes during induction in pediatric acute lymphoblastic leukemia: prevalence, risk factors and characteristics.

Authors:  Dror Koltin; Lillian Sung; Ahmed Naqvi; Stacey L Urbach
Journal:  Support Care Cancer       Date:  2011-11-08       Impact factor: 3.603

2.  Glucose metabolism disorders in children with refractory nephrotic syndrome.

Authors:  Toshiyuki Takahashi; Takayuki Okamoto; Yasuyuki Sato; Asako Hayashi; Yasuhiro Ueda; Tadashi Ariga
Journal:  Pediatr Nephrol       Date:  2020-01-16       Impact factor: 3.714

3.  Prevalence of polycystic ovary syndrome in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  Caiyi Long; Haoyue Feng; Wen Duan; Xin Chen; Yuemeng Zhao; Ying Lan; Rensong Yue
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-31       Impact factor: 6.055

4.  A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.

Authors:  Dora Liu; Alexandra Ahmet; Leanne Ward; Preetha Krishnamoorthy; Efrem D Mandelcorn; Richard Leigh; Jacques P Brown; Albert Cohen; Harold Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-08-15       Impact factor: 3.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.